Archive of all online content
1999 - 2012
| Current Issue: | Recent Issues: | ||
|---|---|---|---|
Vol. 14, Num. 5 |
Vol. 14, Num. 4 |
Vol. 14, Num. 3 |
Vol. 14, Num. 2 |
| Full Text and Abstracts: 2006 - 2012 | ||||||||||
| 2010s | 2010 | 2011 | 2012 | |||||||
| 2000s | 2006 | 2007 | 2008 | 2009 | ||||||
| Full Text (PDF Format Only) and Abstracts: 1999 - 2005 | ||||||||||
| 2000s | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | - | - | - | - |
| 1990s | - | - | - | - | - | - | - | - | - | 1999 |
The Journal
Impact factor: 5.483
5-Yr impact factor: 6.043
Also affiliated with
For Authors
Alerting Services
Corporate Services
Most
-
Most Read
- Symptoms and problems in the end-of-life phase of high-grade glioma patients
- MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity
- Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: Pitfalls in neurooncology
- The treatment of malignant brain tumors in infants and very youngchildren: An update of the Pediatric Oncology Group experience
- Abstracts from the Thirteenth International Symposium on Pediatric Neuro-Oncology
-
Most Cited
- Epidemiology of primary brain tumors: Current concepts and review of theliterature
- Primary and secondary glioblastomas: From concept to clinicaldiagnosis
- Progression-free survival: An important end point in evaluating therapy for recurrent high-grade gliomas
- Patient tumor EGFR and PDGFRA gene amplificationsretained in an invasive intracranial xenograft model of glioblastomamultiforme
- A phase 3 trial of local chemotherapy with biodegradable carmustine(BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma